.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
AstraZeneca
Federal Trade Commission
Moodys
US Department of Justice
Novartis
Citi
Accenture
Chubb
McKinsey

Generated: December 14, 2017

DrugPatentWatch Database Preview

Palbociclib - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for palbociclib and what is the scope of palbociclib patent protection?

Palbociclib
is the generic ingredient in one branded drug marketed by Pfizer Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Palbociclib has sixty-six patent family members in forty-seven countries and five supplementary protection certificates in five countries.

Two suppliers are listed for this compound.

Summary for palbociclib

Pharmacology for palbociclib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-003Feb 3, 2015RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-003Feb 3, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-001Feb 3, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-001Feb 3, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-002Feb 3, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-002Feb 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-001Feb 3, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-002Feb 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-003Feb 3, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncIBRANCEpalbociclibCAPSULE;ORAL207103-002Feb 3, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: palbociclib

Country Document Number Estimated Expiration
Norway20043484► Subscribe
El Salvador2004001459► Subscribe
Morocco27166► Subscribe
LithuaniaPA2017013► Subscribe
Hong Kong1146048► Subscribe
China102295643► Subscribe
Nicaragua200300008► Subscribe
Hong Kong1162026► Subscribe
TunisiaSN04126► Subscribe
South Korea100669578► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PALBOCICLIB

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017013Lithuania► SubscribePRODUCT NAME: PALBOCIKLIBAS, PASIRINKTINAI FARMACINIU POZIURIU PRIIMTINOS DRUSKOS, ESTERIO, AMIDO ARBA PROVAISTO PAVIDALU; REGISTRATION NO/DATE: EU/1/16/1147 20161109
0170012 00212Estonia► SubscribePRODUCT NAME: PALBOTSIKLIIB;REG NO/DATE: EU/1/16/1147 11.11.2016
2017 00010Denmark► SubscribePRODUCT NAME: PALBOCICLIB, EVENTUELT I FORM AF EN FARMACEUTISK ACCEPTABEL ESTER ELLER ET FARMACEUTISK ACCEPTABELT SALT, AMID ELLER PRODRUG; REG. NO/DATE: EU/1/16/1147/001-006 20161111
2017000014Germany► SubscribePRODUCT NAME: PALBOCICLIB, OPTIONAL IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, ESTERS, AMIDES ODER EINES PRODRUGS HIERVON; REGISTRATION NO/DATE: EU/1/16/1147 20161109
0863Netherlands► SubscribePRODUCT NAME: PALBOCICLIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/16/1147 20161111
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Express Scripts
US Army
Argus Health
Colorcon
UBS
QuintilesIMS
Boehringer Ingelheim
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot